Arkolith/Insider Trading/ALXN/Form 4

Mollen John T

DirectorALEXION PHARMACEUTICALS, INC. (ALXN) · full profile →Form 4 · filed Jul 23, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 21, 2021Disposed to issuer(D)15K—$00

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 21, 2021Disposed to issuer(D)3K$159.70$445K0
Jul 21, 2021Disposed to issuer(D)2K$155.01$363K0
Jul 21, 2021Disposed to issuer(D)2K$138.86$319K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899866-21-000071) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML